Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study - Quiz - MDSpire

Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study

  • By

  • Frederique St-Pierre

  • Subodh Bhatta

  • Peter G. Doukas

  • Madeline Jenkin

  • Kaitlin Annunzio

  • Alexandra E. Rojek

  • Alyssa Gibson

  • Yun Kyoung Tiger

  • Brittany McCall

  • Khaled Alhamad

  • Alec Hansen

  • Juan P. Alderuccio

  • Olutobi Adewale

  • Keem Patel

  • Asaad Trabolsi

  • Izidore S. Lossos

  • Lindsey Fitzgerald

  • Thomas A. Ollila

  • Matthew J. Matasar

  • Justin Kline

  • Reem Karmali

  • Narendranath Epperla

  • June 21, 2025

  • 0 min

Share

Original Source(s)

Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study

  • by Frederique St-Pierre, Subodh Bhatta, Peter G. Doukas, Madeline Jenkin, Kaitlin Annunzio, Alexandra E. Rojek, Alyssa Gibson, Yun Kyoung Tiger, Brittany McCall, Khaled Alhamad, Alec Hansen, Juan P. Alderuccio, Olutobi Adewale, Keem Patel, Asaad Trabolsi, Izidore S. Lossos, Lindsey Fitzgerald, Thomas A. Ollila, Matthew J. Matasar, Justin Kline, Reem Karmali, Narendranath Epperla

  • June 21, 2025

Related Content

Multi-strategy feature selection and multi-model machine learning for prognostic prediction in primary gastric diffuse large B-cell lymphoma

Evaluating the Diagnostic Utility of High-Frame-Rate Contrast-Enhanced Ultrasound and a Nomogram for Lymphoma Assessment

Creation and internal assessment of a nomogram tailored for lymphoma to forecast venous thromboembolism risk: analysis of a retrospective cohort comprising 790 patients